Heterologous Prime-boost Immunization With an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming With an Inactivated SARS-CoV-2 Vaccine
Condition(s):COVID-19Last Updated:August 16, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:August 16, 2022Active, not recruiting
Condition(s):COVID-19 Infection; Hematopoietic and Lymphoid System Neoplasm; Leukemia; Lymphoma; Plasma Cell MyelomaLast Updated:April 28, 2023Recruiting
Condition(s):High Sensitivity and Specificity (With 95% Confidence Interval) of RealDetectâ„¢ COVID-19 RT-PCR KitLast Updated:May 28, 2020Unknown status
Condition(s):Covid19Last Updated:September 22, 2021Completed
Condition(s):COVID-19Last Updated:September 3, 2020Unknown status
Condition(s):COVID-19Last Updated:May 17, 2022Active, not recruiting
Condition(s):SARS-CoV-2 InfectionLast Updated:September 27, 2022Completed
Condition(s):COVID-19Last Updated:February 18, 2022Completed
Condition(s):Covid19; SARS-CoV-2Last Updated:March 20, 2023Completed
Condition(s):Sars-CoV2Last Updated:June 9, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.